Musculoskeletal complications in patients with diabetes mellitus

키워드

참고문헌 (117)

1. International Diabetes Federation, "IDF Diabetes Atlas" (2019), International Diabetes Federation
2. 정찬희, "Diabetes Fact Sheets in Korea, 2020: An Appraisal of Current Status", Diabetes and Metabolism Journal, 45(1), pp.1~10 (2021), 대한당뇨병학회[DOI]
3. Oh SH, "Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults : a population-based study using administrative data", BMC Public Health, 21, pp.548~ (2021)
4. Harding JL, "Global trends in diabetes complications : a review of current evidence", Diabetologia, 62, pp.3~16 (2019)
5. Pandey A, "Prevalence of hand disorders in type 2 diabetes mellitus and its correlation with microvascular complications", Ann Med Health Sci Res, 3, pp.349~354 (2013)
6. Adriaanse MC, "The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients", Qual Life Res, 25, pp.175~182 (2016)
7. Monnier VM, "Plasma advanced glycation end products and the subsequent risk of microvascular complications in type 1 diabetes in the DCCT", EDIC, 2022, pp.10, e002667~
8. Khalid M, "Advanced glycation end products and diabetes mellitus : mechanisms and perspectives", Biomolecules, 12, pp.542~ (2022)
9. Holte KB, "Hand, shoulder and back stiffness in long-term type 1 diabetes; cross-sectional association with skin collagen advanced glycation end-products : the Dialong study", J Diabetes Complications, 31, pp.1408~1414 (2017)
10. Avery NC, "The effects of the Maillard reaction on the physical properties and cell interactions of collagen", Pathol Biol(Paris), 54, pp.387~395 (2006)
11. Boivin GP, "Biomechanical properties and histology of db", db diabetic mouse Achilles tendon, 2014, pp.4, 280~284
12. Reddy GK, "Glycation-induced matrix stability in the rabbit Achilles tendon", Arch Biochem Biophys, 399, pp.174~180 (2002)
13. Reddy GK, "Cross-linking in collagen by nonenzymatic glycation increases the matrix stiffness in rabbit Achilles tendon", Exp Diabesity Res, 5, pp.143~153 (2004)
14. Valencia JV, "Advanced glycation end product ligands for the receptor for advanced glycation end products : biochemical characterization and formation kinetics", Anal Biochem, 324, pp.68~78 (2004)
15. Franke S, "Advanced glycation end products induce cell cycle arrest and proinflammatory changes in osteoarthritic fibroblast-like synovial cells", Arthritis Res Ther, 11, pp.R136~ (2009)
16. Handa A, "Vascular endothelial growth factor 121 and 165 in the subacromial bursa are involved in shoulder joint contracture in type II diabetics with rotator cuffdisease", J Orthop Res, 21, pp.1138~1144 (2003)
17. Brownlee M, "The pathobiology of diabetic complications : a unifying mechanism", Diabetes, 54, pp.1615~1625 (2005)
18. Larkin ME, "Musculoskeletal complications in type 1 diabetes", Diabetes Care, 37, pp.1863~1869 (2014)
19. Arkkila PE, "Limited joint mobility in non-insulin-dependent diabetic(NIDDM)patients : correlation to control of diabetes, atherosclerotic vascular disease, and other diabetic complications", J Diabetes Complications, 11, pp.208~217 (1997)
20. Silverstein JH, "Longterm glycemic control influences the onset of limited joint mobility in type 1 diabetes", J Pediatr, 132, pp.944~947 (1998)
21. Kapoor A, "Contractures in diabetes mellitus : the syndrome of limited joint mobility", Semin Arthritis Rheum, 18, pp.168~180 (1989)
22. Lundbaek K, "Stiffhands in long-term diabetes", Acta Med Scand, 158, pp.447~451 (1957)
23. Sozen T, "Musculoskeletal problems in diabetes mellitus", Eur J Rheumatol, 5, pp.258~265 (2018)
24. Gerrits EG, "Limited joint mobility syndrome in diabetes mellitus : a minireview", World J Diabetes, 6, pp.1108~1112 (2015)
25. Hill NE, "Cheiroarthropathy and tendinopathy in diabetes", Diabet Med, 36, pp.939~947 (2019)
26. Al-Homood IA, "Rheumatic conditions in patients with diabetes mellitus", Clin Rheumatol, 32, pp.527~533 (2013)
27. Lopez-Martin I, "Association between limited joint mobility syndrome and risk of accidental falls in diabetic patients", Semergen, 41, pp.70~75 (2015)
28. Zimny S, "The role of limited joint mobility in diabetic patients with an at-risk foot", Diabetes Care, 27, pp.942~946 (2004)
29. Francia P, "Diabetic foot and exercise therapy : step by step the role of rigid posture and biomechanics treatment", Curr Diabetes Rev, 10, pp.86~99 (2014)
30. Abate M, "Management of limited joint mobility in diabetic patients", Diabetes Metab Syndr Obes, 6, pp.197~207 (2013)
31. Olney RK, "Carpal tunnel syndrome : complex issues with a"simple"condition", Neurology, 56, pp.1431~1432 (2001)
32. Atroshi I, "Prevalence of carpal tunnel syndrome in a general population", JAMA, 282, pp.153~158 (1999)
33. Perkins BA, "Carpal tunnel syndrome in patients with diabetic polyneuropathy", Diabetes Care, 25, pp.565~569 (2002)
34. Pourmemari MH, "Diabetes as a risk factor for carpal tunnel syndrome : a systematic review and meta-analysis", Diabet Med, 33, pp.10~16 (2016)
35. Rydberg M, "Diabetic hand : prevalence and incidence of diabetic hand problems using data from 1. 1million inhabitants in southern Sweden", BMJ Open Diabetes Res Care, 10, pp.e002614~ (2022)
36. Padua L, "Carpal tunnel syndrome : clinical features, diagnosis, and management", Lancet Neurol, 15, pp.1273~1284 (2016)
37. Atroshi I, "Methylprednisolone injections for the carpal tunnel syndrome : a randomized, placebo-controlled trial", Ann Intern Med, 159, pp.309~317 (2013)
38. Shi Q, "Is surgical intervention more effective than non-surgical treatment for carpal tunnel syndrome? : a systematic review", J Orthop Surg Res, 6, pp.17~ (2011)
39. Makepeace A, "Incidence and determinants of carpal tunnel decompression surgery in type 2 diabetes : the Fremantle Diabetes Study", Diabetes Care, 31, pp.498~500 (2008)
40. Jeanmonod R, "Trigger finger. In:StatPearls" (2022), StatPearls Publishing
41. Blyth MJ, "Diabetes and trigger finger", J Hand Surg Br, 21, pp.244~245 (1996)
42. Vance MC, "The association of hemoglobin A1c with the prevalence of stenosing flexor tenosynovitis", J Hand Surg Am, 37, pp.1765~1769 (2012)
43. Fitzgibbons PG, "Hand manifestations of diabetes mellitus", J Hand Surg Am, 33, pp.771~775 (2008)
44. Ferrara PE, "Physical therapies for the conservative treatment of the trigger finger : a narrative review", Orthop Rev(Pavia), 12(Suppl 1), pp.8680~ (2020)
45. Kuczmarski AS, "Management of diabetic trigger finger", J Hand Surg Am, 44, pp.150~153 (2019)
46. Noble J, "Diabetes mellitus in the aetiology of Dupuytren’s disease", J Bone Joint Surg Br, 66, pp.322~325 (1984)
47. Hart MG, "Clinical associations of Dupuytren’s disease", Postgrad Med J, 81, pp.425~428 (2005)
48. Trojian TH, "Dupuytren’s disease : diagnosis and treatment", Am Fam Physician, 76, pp.86~89 (2007)
49. Hurst LC, "Injectable collagenase clostridium histolyticum for Dupuytren’s contracture", N Engl J Med, 361, pp.968~979 (2009)
50. Norotte G, "A ten years follow-up of the results of surgery for Dupuytren’s disease : a study of fifty-eight cases", Ann Chir Main, 7, pp.277~281 (1988)
51. St Angelo JM, "StatPearls" (2022), StatPearls Publishing
52. Baslund B, "Frozen shoulder : current concepts", Scand J Rheumatol, 19, pp.321~325 (1990)
53. Balci N, "Shoulder adhesive capsulitis and shoulder range of motion in type II diabetes mellitus : association with diabetic complications", J Diabetes Complications, 13, pp.135~140 (1999)
54. Huang YP, "Association of diabetes mellitus with the risk of developing adhesive capsulitis of the shoulder: a longitudinal population-based follow up study", Arthritis Care Res(Hoboken), 65, pp.1197~1202 (2013)
55. Gundtoft PH, "Diabetes mellitus affects the prognosis of frozen shoulder", Dan Med J, 67, pp.A02200071~ (2020)
56. Lewis J, "Frozen shoulder contracture syndrome : aetiology, diagnosis and management", Man Ther, 20, pp.2~9 (2015)
57. Whelton C, "Review of diabetic frozen shoulder", Eur J Orthop Surg Traumatol, 28, pp.363~371 (2018)
58. Titchener AG, "Comorbidities in rotator cuffdisease : a case-control study", J Shoulder Elbow Surg, 23, pp.1282~1288 (2014)
59. Lin TT, "The effect of diabetes, hyperlipidemia, and statins on the development of rotator cuffdisease : a nationwide, 11-year, longitudinal, population-based follow-up study", Am J Sports Med, 43, pp.2126~2132 (2015)
60. Chi AS, "Non-contrast MRI diagnosis of adhesive capsulitis of the shoulder", Clin Imaging, 44, pp.46~50 (2017)
61. Robinson CM, "Frozen shoulder", J Bone Joint Surg Br, 94, pp.1~9 (2012)
62. 조장혁, "Updates on the treatment of adhesive capsulitis with hydraulic distension", Journal of Yeungnam Medical Science, 38(1), pp.19~26 (2021), 영남대학교 의과대학[DOI]
63. Edmonds ME, "Progress in care of the diabetic foot", Lancet, 354, pp.270~272 (1999)
64. Charcot M, "Demonstration of arthropathic affections of locomotor ataxy", Br Med J, 2, pp.285~ (1881)
65. Trieb K, "The Charcot foot: pathophysiology, diagnosis and classification", Bone Joint J, 98(B), pp.1155~1159 (2016)
66. Schoots IG, "Neuro-osteoarthropathy of the foot-radiologist : friend or foe?", Semin Musculoskelet Radiol, 14, pp.365~376 (2010)
67. Marmolejo VS, "Charcot foot : clinical clues, diagnostic strategies, and treatment principles", Am Fam Physician, 97, pp.594~599 (2018)
68. Rosenbaum AJ, "Classifications in brief : Eichenholtz classification of Charcot arthropathy", Clin Orthop Relat Res, 473, pp.1168~1171 (2015)
69. Schmidt BM, "Updates on diabetic foot and Charcot osteopathic arthropathy", Curr Diab Rep, 18, pp.74~ (2018)
70. Guven MF, "Conservative and surgical treatment of the chronic Charcot foot and ankle", Diabet Foot Ankle, 4, pp.21177~ (2013)
71. Martillo MA, "The crystallization of monosodium urate", Curr Rheumatol Rep, 16, pp.400~ (2014)
72. Vuorinen-Markkola H, "Hyperuricemia and insulin resistance", J Clin Endocrinol Metab, 78, pp.25~29 (1994)
73. Liu Q, "Prevalence and clinical factors associated with gout in patients with diabetes and prediabetes", Rheumatology(Oxford), 51, pp.757~759 (2012)
74. Pan A, "Bidirectional association between diabetes and gout : the Singapore Chinese Health Study", Sci Rep, 6, pp.25766~ (2016)
75. Lai HM, "Gout and type 2 diabetes have a mutual inter-dependent effect on genetic risk factors and higher incidences", Rheumatology(Oxford), 51, pp.715~720 (2012)
76. Engel B, "Treatment options for gout", Dtsch Arztebl Int, 114, pp.215~222 (2017)
77. NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy, "Osteoporosis prevention, diagnosis, and therapy", JAMA, 285, pp.785~795 (2001)
78. Vestergaard P, "Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes : a meta-analysis", Osteoporos Int, 18, pp.427~444 (2007)
79. Thong EP, "Fracture risk in young and middle-aged adults with type 1 diabetes mellitus: a systematic review and meta-analysis", Clin Endocrinol(Oxf), 89, pp.314~323 (2018)
80. Ni Y, "Diabetes mellitus is a risk factor for low bone mass-related fractures: a meta-analysis of cohort studies", Medicine(Baltimore), 96, pp.e8811~ (2017)
81. Bonds DE, "Risk of fracture in women with type 2 diabetes : the Women’s Health Initiative Observational Study", J Clin Endocrinol Metab, 91, pp.3404~3410 (2006)
82. Schwartz AV, "Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial", Diabetes Care, 35, pp.1525~1531 (2012)
83. Li CI, "Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes : a competing risk analysis of Taiwan Diabetes Cohort Study", J Bone Miner Res, 30, pp.1338~1346 (2015)
84. Oei L, "High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control : the Rotterdam Study", Diabetes Care, 36, pp.1619~1628 (2013)
85. Moayeri A, "Fracture risk in patients with type 2 diabetes mellitus and possible risk factors : a systematic review and meta-analysis", Ther Clin Risk Manag, 13, pp.455~468 (2017)
86. Vestergaard P, "Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes", Calcif Tissue Int, 84, pp.45~55 (2009)
87. Hough FS, "Mechanisms in endocrinology : mechanisms and evaluation of bone fragility in type 1diabetes mellitus", Eur J Endocrinol, 174, pp.R127~R138 (2016)
88. Napoli N, "Mechanisms of diabetes mellitus-induced bone fragility", Nat Rev Endocrinol, 13, pp.208~219 (2017)
89. Schwartz AV, "Older women with diabetes have a higher risk of falls : a prospective study", Diabetes Care, 25, pp.1749~1754 (2002)
90. Loke YK, "Long-term use of thiazolidinediones and fractures in type 2 diabetes : a meta-analysis", CMAJ, 180, pp.32~39 (2009)
91. Watts NB, "Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus", J Clin Endocrinol Metab, 101, pp.157~166 (2016)
92. Wiviott SD, "Dapagliflozin and cardiovascular outcomes in type 2 diabetes", N Engl J Med, 380, pp.347~357 (2019)
93. Zinman B, "Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes", N Engl J Med, 373, pp.2117~2128 (2015)
94. Cheng L, "Risk of bone fracture associated with sodium-glucose cotransporter-2 inhibitor treatment : a meta-analysis of randomized controlled trials", Diabetes Metab, 45, pp.436~445 (2019)
95. Ferrari SL, "Diagnosis and management of bone fragility in diabetes : an emerging challenge", Osteoporos Int, 29, pp.2585~2596 (2018)
96. Utsinger PD, "Diffuse idiopathic skeletal hyperostosis", Clin Rheum Dis, 11, pp.325~351 (1985)
97. Pillai S, "Metabolic factors in diffuse idiopathic skeletal hyperostosis : a review of clinical data", Open Rheumatol J, 8, pp.116~128 (2014)
98. Vaishya R, "Diffuse idiopathic skeletal hyperostosis(DISH) : a common but less known cause of back pain", J Clin Orthop Trauma, 8, pp.191~196 (2017)
99. Angelopoulou F, "DISH vs spondyloarthritides", Mediterr J Rheumatol, 31, pp.81~83 (2020)
100. Mader R, "Diffuse idiopathic skeletal hyperostosis(DISH) : where we are now and where to go next", RMD Open, 3, pp.e000472~ (2017)
101. Mader R, "Diffuse idiopathic skeletal hyperostosis : clinical features and pathogenic mechanisms", Nat Rev Rheumatol, 9, pp.741~750 (2013)
102. Guillet C, "Insulin resistance: a contributing factor to age-related muscle mass loss?", Diabetes Metab, 31(Spec No 2), pp.5S20~5S26 (2005)
103. Park SW, "Decreased muscle strength and quality in older adults with type 2 diabetes : the health, aging, and body composition study", Diabetes, 55, pp.1813~1818 (2006)
104. Park SW, "Excessive loss of skeletal muscle mass in older adults with type 2 diabetes", Diabetes Care, 32, pp.1993~1997 (2009)
105. Kim KS, "Type 2diabetes is associated with low muscle mass in older adults", Geriatr Gerontol Int, 14(Suppl 1), pp.115~121 (2014)
106. Kang S, "Sex differences in sarcopenia and frailty among community-dwelling Korean older adults with diabetes : the Korean Frailty and Aging Cohort Study", J Diabetes Investig, 12, pp.155~164 (2021)
107. Mesinovic J, "Sarcopenia and type 2 diabetes mellitus : a bidirectional relationship", Diabetes Metab Syndr Obes, 12, pp.1057~1072 (2019)
108. Srikanthan P, "Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia : findings from the National Health and Nutrition Examination Survey III", PLoS One, 5, pp.e10805~ (2010)
109. Srikanthan P, "Relative muscle mass is inversely associated with insulin resistance and prediabetes : findings from the third National Health and Nutrition Examination Survey", J Clin Endocrinol Metab, 96, pp.2898~2903 (2011)
110. Moon SS, "Low skeletal muscle mass is associated with insulin resistance, diabetes, and metabolic syndrome in the Korean population : the Korea National Health and Nutrition Examination Survey(KNHANES)2009-2010", Endocr J, 61, pp.61~70 (2014)
111. Kim TN, "Relationships between sarcopenic obesity and insulin resistance, inflammation, and vitamin D status: the Korean Sarcopenic Obesity Study", Clin Endocrinol(Oxf), 78, pp.525~532 (2013)
112. Morais JA, "Effects of aging and insulin resistant states on protein anabolic responses in older adults", Exp Gerontol, 108, pp.262~268 (2018)
113. Bian AL, "A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α", Eur J Med Res, 22, pp.25~ (2017)
114. Yong TY, "Diabetic muscle infarction in end-stage renal disease : a scoping review on epidemiology, diagnosis and treatment", World J Nephrol, 7, pp.58~64 (2018)
115. Trujillo-Santos AJ, "Diabetic muscle infarction : an underdiagnosed complication of long-standing diabetes", Diabetes Care, 26, pp.211~215 (2003)
116. Horton WB, "Diabetic muscle infarction : a systematic review", BMJ Open Diabetes Res Care, 3, pp.e000082~ (2015)
117. Morcuende JA, "Diabetic muscle infarction", Iowa Orthop J, 20, pp.65~74 (2000)

관련 논문AI추천